Vinay Kumar Gupta, MD| Surgical Oncology | MedStar Health
About me
Vinay Gupta, MD, is a fellowship-trained surgical oncologist who practices at MedStar Health. He specializes in the treatment of pancreas, liver, stomach, colon and rectum, and breast cancers, as well as soft tissue sarcomas and melanoma. Recognized as one of the most experienced surgical oncologists in the region, he has been named a “Top Doctor” by Baltimore magazine six times.
Dr. Gupta sees patients at both MedStar Franklin Square Medical Center and MedStar Good Samaritan Hospital. He is part of a multidisciplinary team of oncology experts who meet regularly to review patient cases, analyze imaging, and partner to develop plan of care recommendations that are believed to result in the best possible clinical outcomes. These collaborations are especially important to Dr. Gupta, whose patients often do not experience concerning symptoms at the onset of disease, and as a result, are sometimes not diagnosed until later stages.
Dr. Gupta earned his medical degree from the University of Maryland. He went on to complete his general surgery residency at the Medical College of Georgia, followed by a fellowship in surgical oncology at the University of Chicago Hospitals. Today, he serves as cancer liaison physician for the American College of Surgeons Commission on Cancer. Additionally, he teaches and mentors future surgeons as Associate Program Director of the general surgery residency program at MedStar Health Baltimore.
Dr. Gupta’s Philosophy of Care
“Cancer is a very personal disease. But it’s part of why I love being a surgical oncologist. Performing surgery is a big part of what I do, but equally important is that I give my patients hope. Our team helps each patient decide which way to go from a treatment standpoint, and then we navigate them through, applying holistic approaches to care and applying the latest science to achieve the best possible outcomes.”
Clinical areas of focus
- Liver Cancer
- Melanoma
- Merkel Cell Carcinoma
- Pancreas Cancer
- Thyroid Cancer
Conditions and procedures
Conditions I treat
- Acral Lentiginous Melanoma
- Anal Cancer
- Appendiceal Cancer
- Bile Duct Mass
- Biliary Colic
- Cholecystitis
- Colonic Volvulus
- Colorectal Malignancy
- Gallbladder Cancer
- Gallbladder Disease
- Gastrointestinal (GI) Cancer
- Gastrointestinal (GI) Stromal Tumors
- Intra Abdominal Cancer
- Lipomas
- Liver Cancer
- Lymphadenopathy
- Malignant Carcinoid Tumor Of Colon
- Mass On Trunk
- Melanoma
- Merkel Cell Carcinoma
- Mesenteric Mass
- Pancreas Cancer
- Pancreaticobiliary Disease
- Parathyroid Disease
- Parathyroid Mass
- Perforation Of Bile Duct
- Perforation Of Gallbladder
- Peridiverticular Abscess
- Rectal Cancer
- Retroperitoneal Liposarcoma
- Sarcoma Of The Abdomen
- Sarcoma Of The Extremities
- Small Intestine Cancer
- Splenic Mass
- Splenomegaly
- Stomach Cancer
- Thyroid Cancer
- Thyroid Nodule
Procedures I perform
- Abdominal Surgery
- Appendectomy
- Axillary Lymphadenectomy
- Breast Biopsy
- Breast Cancer Surgery
- Cholecystectomy
- Colon Cancer Surgery
- Duodenal Ulcer Surgery
- Excisional Biopsy
- Fine Needle Aspiration
- Fine Needle Aspiration Of Thyroid
- Hickman Catheter
- Ileostomy
- Infusaport Placement
- Inguinal Hernia Repair
- Islet Cell Tumor Resection
- Laparoscopic Adrenalectomy
- Laparoscopic Appendectomy
- Laparoscopic Cholecystectomy
- Laparoscopic Gastrostomy
- Laparoscopic Liver Resection
- Laparoscopic Lymph Node Biopsy
- Laparoscopic Pancreatectomy
- Laparoscopic Splenectomy
- Laparoscopy
- Lymph Node Biopsy
- Lysis Of Adhesions
- Mediports
- Minimally Invasive Surgery
- Muscle Biopsy
- Musculoskeletal Biopsy
- Open Biopsy Of Liver
- Pancreatic Debridement
- Pancreatic Surgery
- Pancreaticojejunostomy
- Parathyroidectomy
- Peg (PERCUTANEOUS ENDOSCOPIC GASTROSTOMY)
- Peptic Ulcer Surgery
- Port
- Pyloroplasty
- Quadrantectomy
- Rectal Cancer Surgery
- Repair Of Liver Laceration
- Repair Of Pancreas
- Repair Of Paracolostomy Hernia
- Retroperitoneal Sarcoma Resection
- Sentinel Node Biopsy
- Small Bowel Biopsy
- Soft Tissue Biopsy
- Splenectomy
- Stomach Surgery
- Surgical Management Of Advanced Pancreatic Cancer
- Surgical Treatment Of Crohn's Disease
- Thyroid Surgery
Insurance
MedStar Health accepts most major health insurance plans. If you are uncertain as to whether your individual health insurance plan is accepted at MedStar Health, please call your insurance company.
-
List of insurance plans we accept
- Cigna Achieve Medicare (HMO C-SNP)
- Cigna Choice Fund PPO
- Aetna Managed Choice (POS)
- CareFirst (NCA) Indemnity
- CareFirst BC/BS Advantage Core/Enhanced
- United Navigate
- MedStar Family Choice DC Healthy Families
- United Optimum Choice Preferred (POS) & OCI Direct (HMO)
- Private Health Care Systems (PHCS) (PPO)
- Cigna PPO and PPO Plus
- United Choice
- United Core Essential (HMO)
- Uniformed Services Family Health Plan (USFHP)
- Innovation Health: Open Network Only Plus
- United Choice Plus
- Aetna Elect Choice/ Open Access (POS)
- United Nursing Home Plan (C-SNP
- Kaiser Signature
- Medicaid - Virginia
- United Medicare Advantage DSNP District of Columbia
- Cigna TotalCare (HMO D-SNP)
- Carefirst EPO
- Aetna Open Choice (PPO)
- Aetna Student Health Insurance
- Carefirst BlueChoice Open Access
- United AARP Medicare Complete
- Kaiser Permanente Signature-Added Choice
- Aetna Signature Administrator PPO/TPA
- Aetna Select HMO/HealthFund/Health Network
- CareFirst Group Medicare Advantage prescription drug benefit (PPO)
- CareFirst Group Medicare Advantage
- Aetna Open HMO/Open HMO Option/Open EPO Plus
- Beech Street PPO
- UnitedHealthcare Individual Exchange Plans
- CareFirst NASCO
- Carefirst BlueChoice Opt Out Plus Open Access (POS)
- United Community Plan - Maryland Health Choice Program
- Cigna HMO & Network (HMO)
- CIGNA EPO
- Kaiser Flexible Choice
- Aetna HMO
- United Optimum Choice
- MedStar Family Choice DC Healthcare Alliance
- Traditional Medicare Fee for Service
- United Group Medicare Advantage Plans
- CareFirst MedStar PPO
- Innovation Health: HMO & EPO Plus
- United MD IPA (HMO)
- Cigna POS/Network POS
- Carefirst Blue Preferred PPO
- Innovation Health: Open POS Plus
- Cigna True Choice Plus Medicare (PPO)
- Tricare East Select
- CareFirst MedStar Select PPO
- Kaiser Select-Added Choice
- Carefirst Healthy Blue (HMO/POS)
- Maryland Point of Service Plan (MPOS)
- CareFirst Administrators
- Cigna POS Open Access & Open Access Plus
- HumanaChoice PPO
- Medicaid - District of Columbia
- Federal Employee Program (Std/Basic PPO/Blue Focus)
- Veterans Affairs Community Care Network
- Cigna True Choice Medicare (PPO)
- United GEHA (for all other states) Compass Rose
- Tricare for Life East
- CareFirst Blue Card Program (Out-of-area BCBS plans)
- WellPoint Maryland - Maryland Health Choice
- United MD IPA Preferred (POS)
- Aetna Traditional Choice (PPO)
- Medicaid - Maryland
- Tricare East Prime
- CareFirst Maryland Indemnity or PPO
- Health Services for Children with Special Needs (HSCSN)
- Cigna HMO Open Access
- Aetna Managed Choice Open Access (POS)
- United Golden Rule
- Kaiser HMO Plus and DHMO Plus Member
- Innovation Health: POS Plus
- Aetna HMO-Open Access/Select OA
- Aetna Choice POS & Choice POS II
- United Select Plus (POS)
- Kaiser Medicare Advantage Signature and Select
- Innovation Health: PPO
- United Options (PPO) (includes Empire PPO)
- HumanaChoice Honor’s plan PPO
- HealthyBlue PPO
- I-SNP
- Veterans Affairs Community Care Network (VA CCN)
- Priority Partners - Maryland Health Choice
- Aetna HealthFund/Health Network Option OA
- Aetna Elect Choice/ EPO (Aetna Health Fund)
- Carefirst BlueChoice HMO
- Employee Health Plan (EHP)
- Tricare Reserve Select
- Cigna Alliance Medicare (HMO) |
- Kaiser Medicare Plus
- WellPoint Maryland
- Police and Fire Clinic
- Virginia Premier
- Aetna Quality Point of Service (POS)
- United Erickson Advantage Plans
- United Select HMO - EPO/NPP
- Cigna Indemnity
- Innovation Health: Indemnity
- D-SNP)
- Innovation Health: POS
- Innovation Health: Open POS II
- Aetna Medicare Advantage HMO & PPO Plans
- Cigna Network Open Access
- Cigna Preferred Medicare
- Kaiser Select
- United Mamsi Life & Health
- Innovation Health: Network Only Plus
- Carefirst BlueChoice Opt Out Open Access
- United Student Resources
- Coventry Health Care National Network PPO
- First Health PPO
- Great-West Healthcare POS/CIGNA
- Coventry Health Care of Virginia
- Coventry of Delaware HMO/PPO
- MedStar Family Choice - Maryland Health Choice
Videos
Education
Board Certification: American Board of Surgery, Surgery
Fellowship: University of Chicago (2002)
Residency: Medical College of Georgia School of Medicine (1999)
Graduate: University of Maryland School of Medicine (1993)
Awards
- Baltimore Magazine Top Doctor, 2015-2018, 2020, 2023, 2024
- Maryland State Chair, American College of Surgeons Commission on Cancer, 2012-2018
- Vice Chair, Georgetown University Oncology Institutional Review Board 2009-2012
- Georgetown University Oncology Institutional Review Board 2006-2009
Hospital affiliations
News and publications
- AbdusSamad M, Gaur A, Zhou H, Zapas JL, Gupta VK, Simbulan-Rosenthal CM, McCarron EC, Rosenthal DS. Combination therapy with mebendazole, trametinib and metformin eliminates recalcitrant NRAS mutant, BRAF wild type melanoma cells. American Association of Cancer Research, Abstract, 2015.
- Heitmiller RF and Gupta VK. Apprenticeship: Preserving the Commitment to Surgical Education. Journal of Surgical Education 65(4):259-262, 2008.
- Gupta VK and Heitmiller RF. Union Memorial Hospital: An Insight to the Origin of Community based Surgical Training. Journal of Surgical Education 65(2):162-165, 2008.
- Gupta VK, Park JO, Kurihara T, Koons A, Jaskowiak NT, Kufe DW, Weichselbaum RR, Posner MC. Selective gene expression in a human esophageal adenocarcinoma model using a DF3/MUC1 promoter. Gene Therapy 10(3):206-212, 2003.
- Mauceri HJ, Seetharam S, Beckett MA, Schumm LP, Koons A, Gupta VK, Park JO, Manan A, Lee JY, Montag AG, Kufe DW, Weichselbaum RR. Angiotensin potentiates cyclophosphamide treatment of metastatic disease. Cancer Chemotherapy & Pharmacology 50(5):412-418, 2002.
- Park JO, Lopez CA, Gupta VK, Brown CK, Mauceri HJ, Dara TE, Manan A, Hellman S, Posner MC, Kufe DW, Weichselbaum RR. Transcriptional control of viral gene therapy by cisplatin. Journal of Clinical Investigation 110(3):403-410, 2002.
- Gupta VK, Park JO, Jaskowiak NT, Mauceri HJ, Seetharam S, Kufe DW, Weichselbaum RR, Posner MC. Combined gene therapy and ionizing radiation is a novel approach to treat human esophageal adenocarcinoma. Annals of Surgical Oncology 9(5):500-504, 2002.
- Gupta VK, Jaskowiak NT, Becket MA, Mauceri HJ, Grunstein J, Johnson RS, Calvin DA, Nodzenski E, Pejovic M, Kufe DW, Posner MC, Weichselbaum RR. Vascular endothelial growth factor enhances endothelial cell survival and tumor radioresistance. The Cancer Journal, Scientific American 8(1):47-54, 2002.
- Mauceri HJ, Seetharam S, Beckett MA, Lee JY, Gupta VK, Gately S, Stack MS, Brown CK, Swedberg K, Kufe DW, Weichselbaum RR. Tumor production of angiostatin is enhanced following exposure to TNF alpha. International Journal of Cancer 97(4):410-415, 2002.
- Salloum RM, Jaskowiak NT, Mauceri HJ, Seetharam S, Beckett MA, Koons AM, Hari DM, Gupta VK, Reimer C, Kalluri R, Posner MC, Hellman S, Kufe DW, Weichselbaum RR. NM-3, an isocoumarin, increases the antitumor effects of radiotherapy without toxicity. Cancer Research 60:6958-6963, 2000.
- Gupta VK, Yeh KA, Burke GJ, Wei JP. 99m-Tc sestamibi localized solitary parathyroid adenoma as an indication for limited unilateral surgical exploration. The American Journal of Surgery 176:409-412, 1998.
- Howdieshell TR, Riegner C, Gupta VK, McNeil PL. Normoxic wound fluid contains high levels of vascular endothelial growth factor. Annals of Surgery 228(5):707-715, 1998.
- Gupta VK, McNeil PL, Reigner C, Howdieshell TR. Vascular endothelial growth factor is a key mediator of omental angiogenesis. Surgical Forum, 82nd Annual Clinical Congress 157:746-748, 1996.
- Midis GP, Gupta VK, Fabian DF, Lefor AT. Target cell membrane modification and susceptibility to lymphokine activated killer cell mediated lysis II. Sodium periodate has a differential effect on the lysis of human and murine tumor cells. Journal of Surgical Research 56:146-154, 1994.
- Gupta VK, Midis GP, Fabian DF, Lefor AT. Sodium periodate has a differential effect on the human and murine LAK cell mediated lysis. FASEB Journal 6:A1151, 1992.
- Midis GP, Gupta VK, Fabian DF, Lefor AT. Combined-modality therapy for murine subcutaneous tumors with immunotherapy and hyperthermia. Current Surgery 488:456-457, 1991.